Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 29, 2019	Dec. 30, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net income	$ 136,940	$ 460,115	$ 194,029
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	131,693	128,879	125,687
Share-based compensation	18,676	17,918	20,928
Impairment of long-lived assets	6,999	4,697	4,097
Deferred income tax	837	(6,568)	(119,330)
Non-cash rental expense (income), net	28,202	(17,043)	(11,822)
Change in operating lease liabilities	(41,911)	0	0
Net (recognition) receipt of deferred vendor incentives	(501)	139	1,901
System optimization (gains) losses, net	(1,283)	(463)	39,076
Gain on sale of investments, net	(24,496)	(450,000)	(2,570)
Distributions received from TimWen joint venture	13,400	13,390	11,713
Equity in earnings in joint ventures, net	(8,673)	(8,076)	(7,573)
Long-term debt-related activities, net (see below)	15,317	18,673	12,075
Other, net	(4,838)	5,178	1,253
Changes in operating assets and liabilities:
Accounts and notes receivable, net	16,935	13,226	(17,340)
Inventories	(163)	(434)	(305)
Prepaid expenses and other current assets	(1,569)	6,824	(3,488)
Advertising funds restricted assets and liabilities	(2,720)	13,955	(12,230)
Accounts payable	1,054	(145)	(2,290)
Accrued expenses and other current liabilities	5,034	23,963	4,982
Net cash provided by operating activities	288,933	224,228	238,793
Cash flows from investing activities:
Capital expenditures	(74,453)	(69,857)	(81,710)
Acquisitions	(5,052)	(21,401)	(86,788)
Dispositions	3,448	3,223	81,516
Proceeds from sale of investment	24,496	450,000	4,111
Notes receivable, net	(3,370)	959	(9,000)
Payments for investments	0	13	375
Net cash (used in) provided by investing activities	(54,931)	362,911	(92,246)
Cash flows from financing activities:
Proceeds from long-term debt	850,000	934,837	31,130
Repayments of long-term debt	(899,800)	(894,501)	(52,593)
Repayments of finance lease liabilities	(6,835)
Repayments of finance lease liabilities		(5,571)	(5,520)
Deferred financing costs	(14,008)	(17,340)	(1,424)
Repurchases of common stock, including accelerated share repurchase	(217,797)	(269,809)	(126,231)
Dividends	(96,364)	(80,532)	(68,322)
Proceeds from stock option exercises	28,328	45,228	12,884
Payments related to tax withholding for share-based compensation	(8,820)	(11,805)	(5,721)
Contingent consideration payment	0	(6,269)	0
Net cash used in financing activities	(365,296)	(305,762)	(215,797)
Net cash (used in) provided by operations before effect of exchange rate changes on cash	(131,294)	281,377	(69,250)
Effect of exchange rate changes on cash	3,489	(7,689)	6,125
Net (decrease) increase in cash, cash equivalents, and restricted cash	(127,805)	273,688	(63,125)
Cash, cash equivalents and restricted cash at beginning of period	486,512	212,824	275,949
Cash, cash equivalents and restricted cash at end of period	358,707	486,512	212,824
Long-term debt-related activities, net:
Loss on early extinguishment of debt	8,496	11,475	0
Accretion of long-term debt	1,272	1,255	1,237
Amortization of deferred financing costs	5,549	5,943	7,944
Reclassification of unrealized losses on cash flow hedges	0	0	2,894
Long-term debt-related activities, net:	15,317	18,673	12,075
Cash paid for:
Interest	138,270	137,607	128,989
Income taxes, net of refunds	34,798	102,827	29,311
Supplemental non-cash investing and financing activities:
Capital expenditures included in accounts payable	6,026	6,460	5,810
Finance leases	50,061
Finance leases		6,569	276,971
Reconciliation of cash, cash equivalents and restricted cash at end of period:
Total cash, cash equivalents and restricted cash	$ 358,707	$ 486,512	$ 275,949